JP2025512953A5 - - Google Patents
Info
- Publication number
- JP2025512953A5 JP2025512953A5 JP2024559145A JP2024559145A JP2025512953A5 JP 2025512953 A5 JP2025512953 A5 JP 2025512953A5 JP 2024559145 A JP2024559145 A JP 2024559145A JP 2024559145 A JP2024559145 A JP 2024559145A JP 2025512953 A5 JP2025512953 A5 JP 2025512953A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263329583P | 2022-04-11 | 2022-04-11 | |
| US63/329,583 | 2022-04-11 | ||
| PCT/EP2023/059278 WO2023198635A1 (en) | 2022-04-11 | 2023-04-06 | T cell binding proteins |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025512953A JP2025512953A (ja) | 2025-04-22 |
| JPWO2023198635A5 JPWO2023198635A5 (https=) | 2026-04-14 |
| JP2025512953A5 true JP2025512953A5 (https=) | 2026-04-14 |
Family
ID=86226585
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024559145A Pending JP2025512953A (ja) | 2022-04-11 | 2023-04-06 | Ｔ細胞結合タンパク質 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250346681A1 (https=) |
| EP (1) | EP4508080A1 (https=) |
| JP (1) | JP2025512953A (https=) |
| CN (1) | CN118974091A (https=) |
| WO (1) | WO2023198635A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2018308088B2 (en) | 2017-07-25 | 2025-05-29 | Truebinding, Inc. | Treating cancer by blocking the interaction of TIM-3 and its ligand |
| AU2020214796A1 (en) | 2019-01-30 | 2021-07-29 | Truebinding, Inc. | Anti-Gal3 antibodies and uses thereof |
| WO2021242776A2 (en) | 2020-05-26 | 2021-12-02 | Truebinding, Inc. | Methods of treating inflammatory diseases by blocking galectin-3 |
| GB2641580A (en) * | 2024-06-07 | 2025-12-10 | T Therapeutics Ltd | Tumour-transforming multispecific proteins |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5892019A (en) | 1987-07-15 | 1999-04-06 | The United States Of America, As Represented By The Department Of Health And Human Services | Production of a single-gene-encoded immunoglobulin |
| US5736137A (en) | 1992-11-13 | 1998-04-07 | Idec Pharmaceuticals Corporation | Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma |
| WO2016105450A2 (en) * | 2014-12-22 | 2016-06-30 | Xencor, Inc. | Trispecific antibodies |
| SG11201912865VA (en) * | 2017-06-25 | 2020-01-30 | Systimmune Inc | Multi-specific antibodies and methods of making and using thereof |
| CN116948035A (zh) * | 2017-06-25 | 2023-10-27 | 西雅图免疫公司 | 多特异性抗体及其制备和使用方法 |
| EP3732201A4 (en) * | 2017-12-19 | 2022-04-20 | Surrozen Operating, Inc. | WNT SURROGATES AND THEIR USES |
| US20210008113A1 (en) * | 2018-03-27 | 2021-01-14 | Systimmune, Inc. | Methods of making and using guidance and navigation control proteins |
-
2023
- 2023-04-06 JP JP2024559145A patent/JP2025512953A/ja active Pending
- 2023-04-06 US US18/854,215 patent/US20250346681A1/en active Pending
- 2023-04-06 CN CN202380032014.9A patent/CN118974091A/zh active Pending
- 2023-04-06 WO PCT/EP2023/059278 patent/WO2023198635A1/en not_active Ceased
- 2023-04-06 EP EP23719654.8A patent/EP4508080A1/en active Pending